Secondary Prevention of Acute Coronary Events. Reduction Of Cholesterol to Key European Targets: an open-label comparative investigation of efficacy, tolerance and health in 2,072 patients randomised to rosuvastatin or 'standard' simvastatin therapy following hospital admission for new definition myocardial infarction

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2005
This article has no abstract
Epistemonikos ID: 245bbed686302ee9bfdb7286ce9997bdd813da1e
First added on: Jan 18, 2025